Ascletis Selects a Best-in-Class Once-Monthly Subcutaneously Administered Amylin Receptor Agonist, ASC36, for Clinical Development

Ascletis Selects a Best-in-Class Once-Monthly Subcutaneously Administered Amylin Receptor Agonist, ASC36, for Clinical Development

-In head-to-head non-human primate (NHP) studies, average observed half-life of ASC36 was approximately 15 days, 3 -fold longer than petrelintide, which supports once-monthly subcutaneous (SQ) dosing in humans. -ASC36 demonstrated approximately 91 %...

Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement

Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement

The Company Advances Toward European CE Mark Submission with 150 Patients Enrolled; On Track for 2027 Commercial Launch HANGZHOU, China, Oct. 25, 2025 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (2500.HK, hereinafter referred to as the "Company")...

BW Nexus Pte. Ltd. Announces Acquisition of C&B Inc. to Drive Innovation and Service Enhancement

BW Nexus Pte. Ltd. Announces Acquisition of C&B Inc. to Drive Innovation and Service Enhancement

SINGAPORE, Oct. 24, 2025 /PRNewswire/ -- BW Nexus Pte. Ltd, a leading technology solutions provider, is pleased to announce the acquisition of C&B inc., a licensed payment remittance company known for its reliable and customer-centric...

METiS BioTech announces China's First AI-Enabled Formulation Drug Candidate to Complete Phase III Clinical Trial

METiS BioTech announces China's First AI-Enabled Formulation Drug Candidate to Complete Phase III Clinical Trial

MTS-004 Poised to Fill an Unmet Need in the Treatment of Pseudobulbar Affect (PBA) BEIJING, China, Oct. 23, 2025 /PRNewswire/ -- METiS TechBio, a global leader in AI-driven nanodelivery and formulation innovation, today announced that its internally...

Cash payments of up to $350 and other benefits are available for eligible current and former owners and lessees of Certain Hyundai and Kia vehicles

Cash payments of up to $350 and other benefits are available for eligible current and former owners and lessees of Certain Hyundai and Kia vehicles

SEATTLE, June 25, 2025 /PRNewswire/ -- JND Legal Administration A proposed class action settlement has been reached in a lawsuit called In Re: ZF-TRW Airbag Control Units Products Liability Litigation, Case No. 2:19-ml-02905-JAK-JPR (C.D. Cal.). A...

CLO and Coach Announce Global 3D Design Contest: "The Handbag Edit"

CLO and Coach Announce Global 3D Design Contest: "The Handbag Edit"

Top Digital Fashion Design Software Developer and Global Fashion Icon Partner to Empower Next-Gen Handbag Designers NEW YORK, June 3, 2025 /PRNewswire/ -- CLO Virtual Fashion, creator of leading 3D fashion design software CLO, together with...

/C O R R E C T I O N -- OHI Group S.A./

/C O R R E C T I O N -- OHI Group S.A./

LUXEMBOURG, May 30, 2025 /PRNewswire/ -- OHI Group S.A., a societe anonyme organized under laws of Luxembourg (the "Issuer"), today announced that it intends to confidentially submit a draft registration statement on Form F-1 with the U.S....

OHI Group S.A. Announces Intention to Submit Confidential Draft Registration Statement for Proposed U.S. Initial Public Offering

OHI Group S.A. Announces Intention to Submit Confidential Draft Registration Statement for Proposed U.S. Initial Public Offering

LUXEMBOURG, May 29, 2025 /PRNewswire/ -- OHI Group S.A., a societe anonyme organized under laws of Luxembourg (the "Issuer"), today announced that it intends to confidentially submit a draft registration statement on Form F-1 with the U.S....

MBK Partners-Young Poong Submit Shareholder Proposals for Korea Zinc's Annual General Meeting

MBK Partners-Young Poong Submit Shareholder Proposals for Korea Zinc's Annual General Meeting

Key Proposals: Appointment of a Temporary Chair Full Cancellation of Treasury Shares Cash Dividend of KRW 7,500 per Common Share & Reclassification of Discretionary Reserves Election of Up to 17 Directors SEOUL, South Korea, Feb. 21, 2025...

menu
menu